Topics

Ardelyx gets FDA green light for Ibsrela

13:24 EDT 13 Sep 2019 | Drug Store News
pharmacy/ardelyx-gets-fda-green-light-for-ibsrela/">

Ardelyx's Ibsrela is a twice-daily oral pill for IBS-C in adults.

Read More

Original Article: Ardelyx gets FDA green light for Ibsrela

NEXT ARTICLE

More From BioPortfolio on "Ardelyx gets FDA green light for Ibsrela"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...